A major transfer involving Liverpool is nearing completion, with a medical expected to take place today, according to a fresh update.
Journalist Ben Jacobs revealed on X that Jarell Quansah is set to undergo his medical with Bayer Leverkusen on Monday, with a €35 million fee already agreed between the clubs. Add-ons could raise the total value of the deal to over €40 million.
Importantly, Jacobs also noted that Liverpool have secured a buyback clause in the agreement, giving them long-term leverage over the 22-year-old defender’s future — a detail also backed by Fabrizio Romano.
Quansah, a product of Liverpool’s academy and a recent England senior call-up, was seen as one of the club’s brightest defensive prospects.
He ended the summer on a high note, playing a key role in England’s U21 European Championship triumph.
Despite his potential, Quansah saw limited Premier League action after January last season. With Leverkusen back in the Champions League, the Bundesliga side is seen as an ideal next step for his growth.
The transfer marks Liverpool’s third major outgoing this summer, following Caoimhin Kelleher’s move to Brentford and Trent Alexander-Arnold’s switch to Real Madrid.
Liverpool are reportedly still considering defensive reinforcements, with Crystal Palace’s Marc Guehi frequently linked as a possible arrival.
The inclusion of a buyback clause ensures Liverpool can monitor Quansah’s development and retain future control, without stalling his career behind established names like Virgil van Dijk, Ibrahima Konaté, and Joe Gomez.
Quansah’s exit is not believed to be financially linked to Liverpool’s £116m acquisition of Florian Wirtz from Bayer Leverkusen.
Jacobs did not confirm whether the medical will take place in Germany or be conducted by Leverkusen’s staff in the UK, but with both sides keen to wrap things up swiftly, an official announcement could arrive within days.
